Analyst Ratings for Poseida Therapeutics, Inc (PSTX)

PSTX Rating Summary

  |   Expand Research on PSTX
Overall Rating: NEUTRAL   Rating Trend: =   Avg. $ Target: N/A
Rating Score: 2.9 / 10   Percentile Rank: 24%
Date Firm Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
12/2/2024 Piper Sandler Edward Tenthoff Downgrade Neutral
(Overweight)		 10.00
(N/A)		 9.33
(9.50)		 1.82% Details
11/26/2024 H.C. Wainwright Arther He Downgrade Neutral
(Buy)		 N/A
(N/A)		 2.86
(9.50)		 232.17% Details